Surgery Partners (NASDAQ:SGRY) Downgraded by BidaskClub

BidaskClub lowered shares of Surgery Partners (NASDAQ:SGRY) from a hold rating to a sell rating in a research report report published on Saturday, BidAskClub reports.

Other equities analysts have also recently issued reports about the company. Royal Bank of Canada reaffirmed a buy rating and issued a $14.00 target price on shares of Surgery Partners in a report on Wednesday, May 13th. Citigroup raised their price target on Surgery Partners from $10.00 to $15.00 and gave the company a buy rating in a report on Wednesday, May 13th. Benchmark raised Surgery Partners from a hold rating to a buy rating and set a $14.00 price target on the stock in a report on Monday, April 27th. Finally, ValuEngine cut Surgery Partners from a strong-buy rating to a buy rating in a report on Thursday, April 2nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of $15.60.

Shares of Surgery Partners stock opened at $11.24 on Friday. Surgery Partners has a one year low of $4.00 and a one year high of $19.74. The stock’s fifty day moving average is $12.51 and its 200 day moving average is $12.94. The stock has a market cap of $528.93 million, a P/E ratio of -4.63 and a beta of 3.45. The company has a debt-to-equity ratio of 2.84, a quick ratio of 1.37 and a current ratio of 1.49.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Monday, May 11th. The company reported ($0.34) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.62) by $0.28. Surgery Partners had a negative return on equity of 2.21% and a negative net margin of 4.38%. The company had revenue of $441.00 million for the quarter, compared to analysts’ expectations of $377.50 million. Analysts predict that Surgery Partners will post -1.34 EPS for the current year.

Large investors have recently bought and sold shares of the business. Bank of Montreal Can raised its holdings in Surgery Partners by 32.4% during the fourth quarter. Bank of Montreal Can now owns 3,865 shares of the company’s stock valued at $61,000 after acquiring an additional 946 shares during the period. Two Sigma Advisers LP purchased a new position in shares of Surgery Partners during the first quarter valued at about $76,000. Royal Bank of Canada grew its position in shares of Surgery Partners by 199.9% during the first quarter. Royal Bank of Canada now owns 16,156 shares of the company’s stock valued at $106,000 after purchasing an additional 10,769 shares in the last quarter. Citigroup Inc. grew its position in shares of Surgery Partners by 247.4% during the first quarter. Citigroup Inc. now owns 18,713 shares of the company’s stock valued at $122,000 after purchasing an additional 13,327 shares in the last quarter. Finally, Deutsche Bank AG grew its position in shares of Surgery Partners by 164.8% during the first quarter. Deutsche Bank AG now owns 21,326 shares of the company’s stock valued at $139,000 after purchasing an additional 13,273 shares in the last quarter. 93.05% of the stock is currently owned by institutional investors and hedge funds.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Featured Story: Most Active Stocks

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.